CEACAM5 and neoplasm: Repeating the experiment with a different donor T-cell, including mock and 4-1BB variants of the anti-CEA scFab CAR-T cells, also showed similar results with the best tumor inhibition observed in CD28-scFab-CAR-T (Supplementary Figure S3).